entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
100505894,TMEM161B-DT,lncRNA,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,62.7727718234645,-0.146148242703816,0.269390213602363,-0.542515040726536,0.587463748897248,0.961473650102656,NA
100505894,TMEM161B-DT,lncRNA,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,172.934649698825,-0.0990059415783238,0.145071272237461,-0.682464143667708,0.494945508137087,0.96308222060722,patient-derived GBM cell lines (PDGCLs)
100505894,TMEM161B-DT,lncRNA,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,58.0644385618186,-0.216243773239485,0.278866224737584,-0.775439096086208,0.438080240659528,0.844570123940276,A549
100505894,TMEM161B-DT,lncRNA,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,39.5467039258559,0.0107415391540472,0.330928662384517,0.0324587754854738,0.974106191089857,0.993266124570745,A549
100505894,TMEM161B-DT,lncRNA,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,42.661890785262,-0.18076943275908,0.462885930744773,-0.390526954379941,0.696146927738133,0.921090533311727,A549
100505894,TMEM161B-DT,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,87.99316578852,-0.13885735810329,0.199754609673256,-0.695139693298809,0.486967761466365,1,sigmoid colon organoid
100505894,TMEM161B-DT,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,87.99316578852,-0.284260595669889,0.20120085198997,-1.41282003956951,0.157708644468129,0.821849896448628,sigmoid colon organoid
